Botulinum toxin A and the cutaneous nociception in humans: A prospective, double-blind, placebo-controlled, randomized study
- 1 December 2002
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 205 (1), 59-63
- https://doi.org/10.1016/s0022-510x(02)00313-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Botulinum toxin A and chronic low back painNeurology, 2001
- Pharmacology and immunology of botulinum toxin serotypesZeitschrift für Neurologie, 2001
- Reduktion von Schmerzen und Muskelanspannung durch Botulinum-Toxin ADer Nervenarzt, 2001
- How does botulinum toxin work?Annals of Neurology, 2000
- Botulinum Toxin Type A as a Migraine Preventive TreatmentHeadache: The Journal of Head and Face Pain, 2000
- Botulinum toxin (Dysport(R)) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging studyJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Treatment of Chronic Cervical‐Associated Headache With Botulinum Toxin A: A Pilot StudyHeadache: The Journal of Head and Face Pain, 2000
- Comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headacheCurrent Review of Pain, 2000
- DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLISThe Lancet, 1986
- Botulinum toxin blocks quantal but not non-quantal release of ACh at the neuromuscular junctionBrain Research, 1983